Stella Pharma Corporation announces that the results of the Phase II randomiz……
We are pleased to announce that the detailed results of the domestic Phase II c……
We are pleased to announce that the final report has been published for the inv……
The paper published in the International Journal of Pharmaceutics describes the……
We are pleased to announce that the Phase II clinical trial for angiosarc……
We, Stella Pharma, participated in the 2025 Annual Meeting of the American Soci……
Stella Pharma is pleased to announce the results of the Phase II investigator-i……
Stella Pharma announces that it has started the first patient trial for the do……
At the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO),……
We are proud to announce that we will exhibit at the Osaka Healthcare Pavilion ……
We are pleased to announce that we have successfully completed the first shipme……
Stella Pharma Corporation has concluded a Memorandum of Understanding (MOU) to ……
